Found 1764 matching trials
Idarubicin at Different Dosages as Induction Therapy for Newly Diagnosed Acute Myeloid Leukaemia PHASE4 Study Design: Treatment, Randomized, Open Label, Parallel Assignment This s...
Show More Location
Multiple Locations
Learn More & Join Trial
Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled Trial PHASE3 Acute myeloid leukemia (AML) is a disease affecting older adults, although ...
Show More Location
ShengJing Hospital of China Medical University
Learn More & Join Trial
Pilot Study Efficacy and Tolerance Fish Oil Emulsion Daunorubicin and Cytarabine Treatment of AML Younger Patients PHASE2 Pilot study of the efficacy and tolerance of the adjunction of a Fish oil e...
Show More Learn More & Join Trial
Venetoclax, Azacitidine, and Mitoxantrone Hydrochloride Liposome Versus Idarubicin and Cytarabine in Newly Diagnosed AML PHASE3 This study aims to evaluate the efficacy and safety of venetoclax combined ...
Show More Location
The First Affiliated Hospital of Anhui Medical University
Learn More & Join Trial
Allogeneic CAR-T(CT0890B) in NKG2DL+ R/R AML PHASE1 A Clinical Study to Investigate the Safety and Efficacy of CT0890B in Patie...
Show More Location
Peking University People's Hospital
Learn More & Join Trial
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy, work in different ways to stop the g...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Efficacy & Safety of the Oral Neurokinin-1 Antagonist, Aprepitant, in Combo With Ondansetron & Dexamethasone in Patients Undergoing Auto Peripheral Blood Stem Cell Transplantation EARLY_PHASE1 The purpose of this study is to determine the efficacy of aprepitant in pre...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia PHASE1 This multi-center, open-label, Phase 1b study will evaluate the safety, pha...
Show More Location
Multiple Locations
Learn More & Join Trial
Bevacizumab, Cytarabine, and Mitoxantrone on Treating Patients With Hematologic Cancers PHASE2 RATIONALE: Monoclonal antibodies such as bevacizumab can locate cancer cell...
Show More Location
Blood and Marrow Transplant Group of Georgia
Learn More & Join Trial
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS PHASE2 The goals of this study are to learn about the effectiveness, the side-effe...
Show More Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Learn More & Join Trial